Achieving HCV Elimination in the United States: Progress and Next Steps

Expert faculty explore the necessary steps to achieve HCV elimination in this online educational program. Choose from 3 interactive CME/CE-certified video modules, 6 CME/CE-certified Webinars with accompanying downloadable audio and slidesets, and 3 ClinicalThought commentaries that disuss best practices in patient management for specific populations that are essential if HCV elimination is to be a feasible goal.
Mark S. Sulkowski, MD
Program Director
Matthew J. Akiyama, MD, MSc
Daniel Fierer Headshot
Daniel S. Fierer, MD
Jason Grebely, BSc, PhD
W. David Hardy, MD
Arthur Kim, MD
Alain H. Litwin, MD
Debra Newman, PA-C, MPAS, MPH
Christian Ramers Headshot
Christian B. Ramers, MD, MPH
Anne Spaulding, MD, MPH
Jeannette M. Tetrault, MD, FACP, FASAM
Stacey Trooskin, MD, PhD

Persons Who Inject Drugs

This CME/CE-certified interactive video module provides in-depth expert perspectives on critical barriers impeding the diagnosis, treatment, and cure of HCV infection among persons who inject drugs along with an analysis of critical strategies for overcoming these challenges to address both HCV and other important healthcare needs of this vulnerable population.

Mark S. Sulkowski, MD
Program Director
Arthur Kim, MD Christian Ramers Headshot Christian B. Ramers, MD, MPH Jeannette M. Tetrault, MD, FACP, FASAM
Physicians: maximum of 1.75 AMA PRA Category 1 Credits Registered Nurses: 1.7 Nursing contact hours Pharmacists: 1.75 contact hours (0.175 CEUs) Released: April 2, 2019 Expiration: April 1, 2020

People who inject drugs continue to be a marginalized population in the United States with substantial unmet medical needs, including bearing a majority proportion of the burden of HCV infection. What models of care can we implement to improve linkage to care and treatment outcomes?

Alain H. Litwin, MD Released: June 14, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on evidence-based interventions to improve the HCV care cascade for people who inject drugs, including important strategies for overcoming barriers to effective HCV prevention, screening, linkage to care, treatment, and cure in this population, including the critical role of HCV treatment as prevention.

Jason Grebely, BSc, PhD Released: June 21, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on emerging models of HCV care that have the potential to expand diagnosis, treatment, and cure for people who inject drugs, an essential population for reaching the goals of HCV elimination.

Stacey Trooskin, MD, PhD Released: July 10, 2019

This downloadable slideset provides an in-depth review of strategies for overcoming barriers to the elimination of HCV infection among persons who inject drugs.

Arthur Kim, MD Christian Ramers Headshot Christian B. Ramers, MD, MPH Jeannette M. Tetrault, MD, FACP, FASAM Released: April 2, 2019

This downloadable slideset provides an overview of the tools now available to help providers overcome barriers across the HCV care cascade for people who inject drugs, including simplified HCV management strategies and evidence-based interventions to improve linkage to care.

Jason Grebely, BSc, PhD Released: June 18, 2019

This downloadable slideset provides an examination of models of HCV care that aim to help overcome barriers to treatment and cure for people who inject drugs, including intensified linkage to care and on-treatment support strategies.

Stacey Trooskin, MD, PhD Released: June 27, 2019

Men Who Have Sex With Men

This CME/CE-certified interactive video module provides in-depth expert perspectives on barriers impeding expanded treatment and cure of HCV infection among men who have sex with men along with an analysis of critical strategies for preventing HCV infection and promoting sexual health.

Mark S. Sulkowski, MD
Program Director
Daniel Fierer Headshot Daniel S. Fierer, MD W. David Hardy, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Registered Nurses: 1.9 Nursing contact hours Pharmacists: 2.0 contact hours (0.2 CEUs) Released: April 16, 2019 Expiration: April 15, 2020

For practitioners providing care for MSM, how should the established risk for HCV inform your practice? Here’s my take.

W. David Hardy, MD Released: July 18, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on HCV infection risk among MSM living with HIV and important strategies for overcoming barriers to effective HCV prevention, screening, treatment, and care in this population, including the critical role of HCV treatment as prevention.

Mark S. Sulkowski, MD
Program Director
Released: June 19, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on HCV infection risk among MSM without HIV and important strategies for overcoming barriers to effective HCV prevention, screening, treatment, and care in this population, including the critical role of HCV treatment as prevention.

Daniel Fierer Headshot Daniel S. Fierer, MD Released: July 9, 2019

This downloadable slideset provides an in-depth review of strategies for overcoming barriers to the elimination of HCV infection among men who have sex with men, both with and without HIV infection.

Mark S. Sulkowski, MD
Program Director
Daniel Fierer Headshot Daniel S. Fierer, MD W. David Hardy, MD
Released: April 22, 2019

This downloadable slideset provides a review of HCV infection risk among MSM living with HIV and important strategies for overcoming barriers to HCV prevention and elimination in this population, including the critical role of HCV treatment as prevention.

Mark S. Sulkowski, MD
Program Director
Released: June 14, 2019

This downloadable slideset provides a review of HCV infection risk among MSM without HIV and important considerations for preventing and treating HCV in this population, including the critical role of HCV treatment as prevention.

Daniel Fierer Headshot Daniel S. Fierer, MD Released: June 20, 2019

People Who Are Incarcerated

This downloadable slideset provides an examination of the burden of HCV in US correctional facilities; guidelines, challenges, and benefits of HCV screening in jails and prisons; the feasibility of HCV treatment in corrections; and strategies for improving linkage to HCV care upon community re-entry.

Matthew J. Akiyama, MD, MSc Released: October 8, 2019

This CME/CE-certified interactive video module provides in-depth expert analysis of the barriers impeding expanded diagnosis, treatment, and cure of HCV infection among individuals who are incarcerated in jails or prisons along with important insights on critical strategies needed to overcome these challenges.

Mark S. Sulkowski, MD
Program Director
Matthew J. Akiyama, MD, MSc Debra Newman, PA-C, MPAS, MPH Anne Spaulding, MD, MPH
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 6, 2019 Expiration: June 5, 2020

This downloadable slideset provides a review of challenges to eliminating HCV infection among people who are incarcerated and models of care seeking to overcome these barriers.

Matthew J. Akiyama, MD, MSc Debra Newman, PA-C, MPAS, MPH Anne Spaulding, MD, MPH Released: June 6, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on guidelines, challenges, and benefits of HCV screening in jails and prisons; the feasibility of HCV treatment in corrections; and strategies for improving linkage to HCV care upon community re-entry.

Matthew J. Akiyama, MD, MSc Released: October 10, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?